Acute myeloid leukemia (AML) is a type of blood cancer that forms in the soft marrow of the bones, typically attacking cells that would otherwise form the key component of the body's immunodefense system, white blood cells.
New approach for developing cancer vaccines could make immunotherapies more effective in acute myeloid leukemia retrieved 3 May 2024 from https://medicalxpress.com/news/2024-05-approach-cancer-vaccines-immunotherapies-effective.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.6 hours ago Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Study shows GHRH antagonist's role in AML drug resistanceA new research paper was published in Oncotarget's Volume 15 on April 8, 2024, entitled, 'Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia.'
Read more »
Two-punch treatment delivers blood cancer knockout: Study shows drug combo eradicates cancer cells in lab-based testsA novel combination of two cancer drugs has shown great potential as a future treatment for patients with acute myeloid leukemia (AML), one of the most common types of blood cancers. A new study by WEHI researchers has revealed the combination of two existing drugs eradicated AML cancer cells in lab-based tests.
Read more »
Targeting RAS proteins may prevent relapse in acute myeloid leukemiaRelapses in a common form of leukemia may be preventable following new research that has identified how the cancer develops resistance to first line treatments.
Read more »
Understanding Acute Lymphoblastic Leukaemia featured in EmmerdaleThere are sad and upsetting scenes ahead for Emmerdale fans as couple Billy and Dawn Fletcher face news of a devastating leukaemia diagnosis for their baby son Evan, as experts reveal more
Read more »
Surgical Removal Found Beneficial for Acute Intracerebral HemorrhageA recent study suggests that surgical removal is beneficial for patients with acute intracerebral hemorrhage.
Read more »
ACC: Ticagrelor monotherapy cuts bleeding risk in acute coronary syndromeTreatment with ticagrelor alone results in a lower rate of clinically relevant bleeding compared with ticagrelor and aspirin among patients with an acute coronary syndrome who had percutaneous coronary intervention and remained event-free for one month on dual antiplatelet therapy, according to a study published online April 7 in The Lancet to...
Read more »